GI Innovation, Inc. (358570.KQ)

KRW 9790.0

(-4.39%)

Total Assets Summary of GI Innovation, Inc.

  • GI Innovation, Inc.'s latest annual total assets in 2023 was 81.34 Billion KRW , down -23.51% from previous year.
  • GI Innovation, Inc.'s latest quarterly total assets in 2024 Q2 was 56.52 Billion KRW , down -15.38% from previous quarter.
  • GI Innovation, Inc. reported annual total assets of 106.33 Billion KRW in 2022, down -40.88% from previous year.
  • GI Innovation, Inc. reported annual total assets of 179.86 Billion KRW in 2021, up 202.67% from previous year.
  • GI Innovation, Inc. reported quarterly total assets of 66.8 Billion KRW for 2024 Q1, down -17.87% from previous quarter.
  • GI Innovation, Inc. reported quarterly total assets of 81.34 Billion KRW for 2023 FY, down -23.51% from previous quarter.

Annual Total Assets Chart of GI Innovation, Inc. (2023 - 2019)

Historical Annual Total Assets of GI Innovation, Inc. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 81.34 Billion KRW -23.51%
2022 106.33 Billion KRW -40.88%
2021 179.86 Billion KRW 202.67%
2020 59.42 Billion KRW 11.73%
2019 53.19 Billion KRW 0.0%

Peer Total Assets Comparison of GI Innovation, Inc.

Name Total Assets Total Assets Difference
HLB Co., Ltd. 751.72 Billion KRW 89.179%
iNtRON Biotechnology, Inc. 98.61 Billion KRW 17.517%
BINEX Co., Ltd. 257.01 Billion KRW 68.352%
Bioneer Corporation 315.48 Billion KRW 74.218%
Anterogen.Co.,Ltd. 149.43 Billion KRW 45.567%
MEDIPOST Co., Ltd. 449.39 Billion KRW 81.9%
CrystalGenomics, Inc. 243.11 Billion USD 66.543%
Helixmith Co., Ltd 227.27 Billion KRW 64.211%
Chabiotech Co.,Ltd. 1725.57 Billion KRW 95.286%
Medy-Tox Inc. 611.62 Billion KRW 86.701%
Peptron, Inc. 52.49 Billion KRW -54.946%
Amicogen, Inc. 467.09 Billion KRW 82.586%
Genexine, Inc. 376.58 Billion KRW 78.401%
HLB Therapeutics Co.,Ltd. 200.79 Billion KRW 59.491%
LegoChem Biosciences, Inc. 189.5 Billion KRW 57.077%
ALTEOGEN Inc. 256.09 Billion KRW 68.239%
PharmaResearch Co., Ltd. 535.28 Billion KRW 84.804%
SillaJen, Inc. 76.71 Billion KRW -6.029%
JETEMA, Co., Ltd. 252.14 Billion KRW 67.741%
OliX Pharmaceuticals,Inc 102.82 Billion KRW 20.895%
Genomictree Inc. 132.84 Billion KRW 38.77%
MedPacto, Inc. 80.47 Billion KRW -1.076%
D&D Pharmatech 79.2 Billion KRW -2.698%
EASY BIO,Inc. 172.04 Billion KRW 52.721%